BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 31846533)

  • 21. Clinicopathological and genomic characterization of BCORL1-driven high-grade endometrial stromal sarcomas.
    Lin DI; Huang RSP; Mata DA; Decker B; Danziger N; Lechpammer M; Hiemenz M; Ramkissoon SH; Ross JS; Elvin JA
    Mod Pathol; 2021 Dec; 34(12):2200-2210. PubMed ID: 34302054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus.
    Nola M; Babić D; Ilić J; Marusić M; Uzarević B; Petrovecki M; Sabioncello A; Kovac D; Jukić S
    Cancer; 1996 Dec; 78(12):2543-50. PubMed ID: 8952563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uterine sarcomas.
    Mbatani N; Olawaiye AB; Prat J
    Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():51-58. PubMed ID: 30306577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The proto-oncogene c-kit is expressed in leiomyosarcomas of the uterus.
    Wang L; Felix JC; Lee JL; Tan PY; Tourgeman DE; O'Meara AT; Amezcua CA
    Gynecol Oncol; 2003 Aug; 90(2):402-6. PubMed ID: 12893208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic treatment in adult uterine sarcomas.
    Desar IME; Ottevanger PB; Benson C; van der Graaf WTA
    Crit Rev Oncol Hematol; 2018 Feb; 122():10-20. PubMed ID: 29458779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel PLAG1 Gene Rearrangement Distinguishes a Subset of Uterine Myxoid Leiomyosarcoma From Other Uterine Myxoid Mesenchymal Tumors.
    Arias-Stella JA; Benayed R; Oliva E; Young RH; Hoang LN; Lee CH; Jungbluth AA; Frosina D; Soslow RA; Antonescu CR; Ladanyi M; Chiang S
    Am J Surg Pathol; 2019 Mar; 43(3):382-388. PubMed ID: 30489320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Endometrial and other rare uterine sarcomas : Diagnostic aspects in the context of the 2020 WHO classification].
    Mayr D; Horn LC; Hiller GGR; Höhn AK; Schmoeckel E
    Pathologe; 2022 May; 43(3):183-195. PubMed ID: 35362728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PLAG1-rearrangment in a uterine leiomyosarcoma with myxoid stroma and heterologous differentiation.
    Thiryayi SA; Turashvili G; Latta EK; Swanson D; Zhang L; Antonescu CR; Dickson BC
    Genes Chromosomes Cancer; 2021 Oct; 60(10):713-717. PubMed ID: 34184333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical management of uterine sarcomas.
    Amant F; Coosemans A; Debiec-Rychter M; Timmerman D; Vergote I
    Lancet Oncol; 2009 Dec; 10(12):1188-98. PubMed ID: 19959075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathologic Characterization of GREB1-rearranged Uterine Sarcomas With Variable Sex-Cord Differentiation.
    Lee CH; Kao YC; Lee WR; Hsiao YW; Lu TP; Chu CY; Lin YJ; Huang HY; Hsieh TH; Liu YR; Liang CW; Chen TW; Yip S; Lum A; Kuo KT; Jeng YM; Yu SC; Chung YC; Lee JC
    Am J Surg Pathol; 2019 Jul; 43(7):928-942. PubMed ID: 31094921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uterine tumour resembling an ovarian sex cord tumour.
    Sutak J; Lazic D; Cullimore JE
    J Clin Pathol; 2005 Aug; 58(8):888-90. PubMed ID: 16049297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 immunohistochemical analysis of fusion-positive uterine sarcomas.
    Mohammad N; Stewart CJR; Chiang S; Turashvili G; Dickson BC; Ng TL; Köbel M; McCluggage WG; Croce S; Lee CH
    Histopathology; 2021 May; 78(6):805-813. PubMed ID: 33118176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mesenchymal and mixed uterine tumors : Current overview and practical aspects].
    Lax SF
    Pathologe; 2019 Feb; 40(1):36-45. PubMed ID: 30694356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current concepts in the imaging of uterine sarcoma.
    Tirumani SH; Ojili V; Shanbhogue AK; Fasih N; Ryan JG; Reinhold C
    Abdom Imaging; 2013 Apr; 38(2):397-411. PubMed ID: 22699695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant mesenchymal tumors of the uterus - time to advocate a genetic classification.
    Rommel B; Holzmann C; Bullerdiek J
    Expert Rev Anticancer Ther; 2016 Nov; 16(11):1155-1166. PubMed ID: 27602604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations.
    Hoang L; Chiang S; Lee CH
    Pathology; 2018 Feb; 50(2):162-177. PubMed ID: 29275929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SATB2 Expression in Uterine Sarcoma: A Multicenter Retrospective Study.
    Le Page C; Almadani N; Turashvili G; Bataillon G; Portelance L; Provencher D; Mes-Masson AM; Gilks B; Hoang L; Rahimi K
    Int J Gynecol Pathol; 2021 Sep; 40(5):487-494. PubMed ID: 33720083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly Invasive and Metastatic High-grade Endometrial Stromal Sarcoma With
    Ling F; Ruan S; Chen H; Xiong X; Zhao D; Haybaeck J; Zhang C
    In Vivo; 2022; 36(4):1971-1976. PubMed ID: 35738637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelioid endometrial and endometrioid stromal tumors: a report of four cases emphasizing their distinction from epithelioid smooth muscle tumors and other oxyphilic uterine and extrauterine tumors.
    Oliva E; Clement PB; Young RH
    Int J Gynecol Pathol; 2002 Jan; 21(1):48-55. PubMed ID: 11781523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uterine sarcomas: a review.
    D'Angelo E; Prat J
    Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.